131 related articles for article (PubMed ID: 26359623)
1. Monitoring Diabetic Nephropathy by Circulating Gangliosides.
Ene CD; Penescu M; Anghel A; Neagu M; Budu V; Nicolae I
J Immunoassay Immunochem; 2016; 37(1):68-79. PubMed ID: 26359623
[TBL] [Abstract][Full Text] [Related]
2. Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
Shahid SM; Nawab SN; Shaikh R; Mahboob T
Pak J Pharm Sci; 2012 Jan; 25(1):123-9. PubMed ID: 22186319
[TBL] [Abstract][Full Text] [Related]
3. Relationship between serum nitric oxide and sialic acid in coexisted diabetes, hypertension and nephropathy.
Shahid SM; Jawed M; Mahboob T
Pak J Pharm Sci; 2013 May; 26(3):593-7. PubMed ID: 23625435
[TBL] [Abstract][Full Text] [Related]
4. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy.
Yokoyama H; Jensen JS; Jensen T; Deckert T
J Intern Med; 1995 May; 237(5):519-23. PubMed ID: 7738493
[TBL] [Abstract][Full Text] [Related]
5. Study of Irisin Hormone Level in Type 2 Diabetic Patients and Patients with Diabetic Nephropathy.
Shelbaya S; Abu Shady MM; Nasr MS; Bekhet MM; Mageed YA; Abbas M
Curr Diabetes Rev; 2018; 14(5):481-486. PubMed ID: 28875825
[TBL] [Abstract][Full Text] [Related]
6. Relationship between sialic acid and metabolic variables in Indian type 2 diabetic patients.
Nayak SB; Bhaktha G
Lipids Health Dis; 2005 Aug; 4():15. PubMed ID: 16092968
[TBL] [Abstract][Full Text] [Related]
7. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
Lv C; Zhou YH; Wu C; Shao Y; Lu CL; Wang QY
Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368
[TBL] [Abstract][Full Text] [Related]
8. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
Li W; Wang J; Ge L; Shan J; Zhang C; Liu J
Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
[TBL] [Abstract][Full Text] [Related]
9. Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy.
Chen J; Gall MA; Yokoyama H; Jensen JS; Deckert M; Parving HH
Diabetes Care; 1996 Feb; 19(2):130-4. PubMed ID: 8718432
[TBL] [Abstract][Full Text] [Related]
10. Correlation of microalbumin and sialic acid with anthropometric variables in type 2 diabetic patients with and without nephropathy.
Shivananda Nayak B; Duncan H; Lalloo S; Maraj K; Matmungal V; Matthews F; Prajapati B; Samuel R; Sylvester P
Vasc Health Risk Manag; 2008; 4(1):243-7. PubMed ID: 18629366
[TBL] [Abstract][Full Text] [Related]
11. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for early diagnosis of type 2 diabetic nephropathy: a study based on an integrated biomarker system.
Huang M; Liang Q; Li P; Xia J; Wang Y; Hu P; Jiang Z; He Y; Pang L; Han L; Wang Y; Luo G
Mol Biosyst; 2013 Aug; 9(8):2134-41. PubMed ID: 23719966
[TBL] [Abstract][Full Text] [Related]
13. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
Tan SMQ; Chiew Y; Ahmad B; Kadir KA
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227659
[TBL] [Abstract][Full Text] [Related]
14. Relation of serum total sialic acid concentrations with diabetic complications and cardiovascular risk factors in Kuwaiti Type 2 diabetic patients.
Abdella N; Akanji AO; Mojiminiyi OA; Al Assoussi A; Moussa M
Diabetes Res Clin Pract; 2000 Sep; 50(1):65-72. PubMed ID: 10936670
[TBL] [Abstract][Full Text] [Related]
15. Influence of C-reactive protein on the occurrence and assessing of albuminuria severity in diabetics.
Pojskić L; Hasić S; Tahto E; Arnautović-Torlak V; Pojskić B
Med Glas (Zenica); 2018 Feb; 15(1):10-15. PubMed ID: 29214987
[TBL] [Abstract][Full Text] [Related]
16. Association of serum uric acid levels with the risk of development or progression of albuminuria among Japanese patients with type 2 diabetes: a prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 10)].
Hayashino Y; Okamura S; Tsujii S; Ishii H
Acta Diabetol; 2016 Aug; 53(4):599-607. PubMed ID: 26935413
[TBL] [Abstract][Full Text] [Related]
17. Glycemic status, lipid profile and proteinuria in diabetic nephropathy.
Jha P; Das BK; Shrestha S; Majhi S; Chandra L; Sharma S; Baral N
JNMA J Nepal Med Assoc; 2010; 49(178):143-6. PubMed ID: 21485601
[TBL] [Abstract][Full Text] [Related]
18. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
Cardoso CRL; Leite NC; Moram CBM; Salles GF
Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
[TBL] [Abstract][Full Text] [Related]
19. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
[TBL] [Abstract][Full Text] [Related]
20. [Assess the impact of concentrations of inflammatory markers IL-6, CRP in the presence of albuminuria in patients with type 2 diabetes].
Czyzewska J; Wasilewska K; Kamińska J; Koper O; Kemona H; Jakubowska I
Pol Merkur Lekarski; 2012 Feb; 32(188):98-102. PubMed ID: 22590912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
